These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 31229666)
21. Flow cytometric detection of degranulation reveals phenotypic heterogeneity of degranulating CMV-specific CD8+ T lymphocytes in rhesus macaques. Chan KS; Kaur A J Immunol Methods; 2007 Aug; 325(1-2):20-34. PubMed ID: 17628586 [TBL] [Abstract][Full Text] [Related]
22. Human bone marrow as a source to generate CMV-specific CD4+ T cells with multifunctional capacity. Na IK; Letsch A; Guerreiro M; Bauer S; Noack I; Geginat J; Reinke P; Loesch M; Kienapfel H; Thiel E; Volk HD; Scheibenbogen C J Immunother; 2009; 32(9):907-13. PubMed ID: 19816191 [TBL] [Abstract][Full Text] [Related]
23. Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. Bunde T; Kirchner A; Hoffmeister B; Habedank D; Hetzer R; Cherepnev G; Proesch S; Reinke P; Volk HD; Lehmkuhl H; Kern F J Exp Med; 2005 Apr; 201(7):1031-6. PubMed ID: 15795239 [TBL] [Abstract][Full Text] [Related]
24. Rapid monitoring of immune reconstitution after allogeneic stem cell transplantation--a comparison of different assays for the detection of cytomegalovirus-specific T cells. Abu-Khader A; Krause S Eur J Haematol; 2013 Dec; 91(6):534-45. PubMed ID: 23952609 [TBL] [Abstract][Full Text] [Related]
25. Characterization of migratory activity and cytokine profile of helper and cytotoxic CMV-specific T-cell lines expanded by a selective peptide library. Dander E; Li Pira G; Biagi E; Perseghin P; Renoldi G; Gaipa G; Introna M; Marin V; Manca F; Biondi A; D'Amico G Exp Hematol; 2008 Apr; 36(4):473-85. PubMed ID: 18261836 [TBL] [Abstract][Full Text] [Related]
26. CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects. Slezak SL; Bettinotti M; Selleri S; Adams S; Marincola FM; Stroncek DF J Transl Med; 2007 Mar; 5():17. PubMed ID: 17391521 [TBL] [Abstract][Full Text] [Related]
27. Rapid generation of CMV pp65-specific T cells for immunotherapy. Bao L; Sun Q; Lucas KG J Immunother; 2007; 30(5):557-61. PubMed ID: 17589296 [TBL] [Abstract][Full Text] [Related]
28. Purification of Ag-specific T lymphocytes after direct peripheral blood mononuclear cell stimulation followed by CD25 selection. I. Application to CD4(+) or CD8(+) cytomegalovirus phosphoprotein pp65 epitope determination. Gallot G; Vivien R; Ibisch C; Lulé J; Davrinche C; Gaschet J; Vié H J Immunol; 2001 Oct; 167(8):4196-206. PubMed ID: 11591740 [TBL] [Abstract][Full Text] [Related]
29. Poor predictive value of cytomegalovirus (CMV)-specific T cell assays for the development of CMV retinitis in patients with AIDS. Jacobson MA; Tan QX; Girling V; Poon C; Van Natta M; Jabs DA; Inokuma M; Maecker HT; Bredt B; Sinclair E; Clin Infect Dis; 2008 Feb; 46(3):458-66. PubMed ID: 18173357 [TBL] [Abstract][Full Text] [Related]
30. CMV-specific central memory T cells reside in bone marrow. Letsch A; Knoedler M; Na IK; Kern F; Asemissen AM; Keilholz U; Loesch M; Thiel E; Volk HD; Scheibenbogen C Eur J Immunol; 2007 Nov; 37(11):3063-8. PubMed ID: 17960663 [TBL] [Abstract][Full Text] [Related]
31. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus. Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550 [TBL] [Abstract][Full Text] [Related]
32. Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. Kern F; Bunde T; Faulhaber N; Kiecker F; Khatamzas E; Rudawski IM; Pruss A; Gratama JW; Volkmer-Engert R; Ewert R; Reinke P; Volk HD; Picker LJ J Infect Dis; 2002 Jun; 185(12):1709-16. PubMed ID: 12085315 [TBL] [Abstract][Full Text] [Related]
33. Expansion of human cytomegalovirus-specific T lymphocytes from unfractionated peripheral blood mononuclear cells with artificial antigen-presenting cells. Paine A; Oelke M; Blasczyk R; Eiz-Vesper B Transfusion; 2007 Nov; 47(11):2143-52. PubMed ID: 17958544 [TBL] [Abstract][Full Text] [Related]
34. Kinetics of cytomegalovirus (CMV) pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells during episodes of viral DNAemia in allogeneic stem cell transplant recipients: potential implications for the management of active CMV infection. Tormo N; Solano C; Benet I; Nieto J; de la Cámara R; Garcia-Noblejas A; Clari MA; Chilet M; López J; Hernández-Boluda JC; Remigia MJ; Navarro D J Med Virol; 2010 Jul; 82(7):1208-15. PubMed ID: 20513086 [TBL] [Abstract][Full Text] [Related]
35. A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects. Berencsi K; Gyulai Z; Gönczöl E; Pincus S; Cox WI; Michelson S; Kari L; Meric C; Cadoz M; Zahradnik J; Starr S; Plotkin S J Infect Dis; 2001 Apr; 183(8):1171-9. PubMed ID: 11262198 [TBL] [Abstract][Full Text] [Related]
36. Results of a cytomegalovirus (CMV)-specific CD8+/interferon- gamma+ cytokine flow cytometry assay correlate with clinical evidence of protective immunity in patients with AIDS with CMV retinitis. Jacobson MA; Maecker HT; Orr PL; D'Amico R; Van Natta M; Li XD; Pollard RB; Bredt BM; J Infect Dis; 2004 Apr; 189(8):1362-73. PubMed ID: 15073672 [TBL] [Abstract][Full Text] [Related]
37. Influence of HIV infection on cytomegalovirus-specific immunity: T-cell responses to pp65 and IE1 before and after HAART may reflect altered cytomegalovirus biology. Scherrenburg J; Schellens IM; van Baarle D Antivir Ther; 2011; 16(4):565-75. PubMed ID: 21685544 [TBL] [Abstract][Full Text] [Related]
38. Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8(+) T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation. Giménez E; Muñoz-Cobo B; Solano C; Amat P; de la Cámara R; Nieto J; López J; Remigia MJ; Garcia-Noblejas A; Navarro D Transpl Infect Dis; 2015 Jun; 17(3):361-70. PubMed ID: 25850900 [TBL] [Abstract][Full Text] [Related]
39. Rapid, large-scale generation of highly pure cytomegalovirus-specific cytotoxic T cells for adoptive immunotherapy. Foster AE; Gottlieb DJ; Marangolo M; Bartlett A; Li YC; Barton GW; Romagnoli JA; Bradstock KF J Hematother Stem Cell Res; 2003 Feb; 12(1):93-105. PubMed ID: 12662440 [TBL] [Abstract][Full Text] [Related]
40. Cognate CD4 T-cell licensing of dendritic cells heralds anti-cytomegalovirus CD8 T-cell immunity after human allogeneic umbilical cord blood transplantation. Flinsenberg TW; Spel L; Jansen M; Koning D; de Haar C; Plantinga M; Scholman R; van Loenen MM; Nierkens S; Boon L; van Baarle D; Heemskerk MH; Boelens JJ; Boes M J Virol; 2015 Jan; 89(2):1058-69. PubMed ID: 25378489 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]